期刊文献+

糖尿病肾病患者外周血lncRNA ANRIL的表达与左心室肥厚的关系

The expressions of peripheral blood lncRNA ANRIL and association with left ventricular hypertrophy in patients with diabetic kidney disease
原文传递
导出
摘要 目的探讨外周血长链非编码RNA ANRIL(lncRNA ANRIL)在糖尿病肾病(DKD)患者中的表达水平与左心室肥厚(LVH)的关系。方法选取2020年1月至2021年12月在本院收治的66例DKD患者(DKD组),同期选取本院健康体检者20例作为健康对照组,采用qRT-PCR法检测两组受试者外周血lncRNA ANRIL的表达。根据左心室质量指数(LVMI)将DKD组患者分为非LVH组(23例)和LVH组(43例),比较两组患者的外周血lncRNA ANRIL差异,采用logistic回归分析影响DKD患者LVH的危险因素,采用受试者工作特征(ROC)曲线评估外周血lncRNA ANRIL对DKD患者LVH的预测价值。结果DKD组患者的收缩压、舒张压、血肌酐(Scr)、血尿素氮(BUN)、胱抑素C(Cys C)高于健康对照组,而血红蛋白(Hb)、白蛋白(ALB)、估算肾小球滤过率(eGFR)低于健康对照组(均P<0.05)。LVH组患者的尿微量白蛋白肌酐比(ACR)、Scr、BUN、Cys C、尿β2微球蛋白(β2-MG)、LVMI均高于非LVH组;而Hb、ALB、eGFR均低于非LVH组(均P<0.05)。DKD组患者外周血lncRNA ANRIL表达水平高于健康对照组(P<0.001)。外周血lncRNA ANRIL表达水平与BUN、Scr等呈正相关,与eGFR呈负相关(均P<0.05)。LVH组外周血lncRNA ANRIL表达水平高于非LVH组(P<0.05)。LVMI与收缩压、舒张压、ACR等呈正相关,与Hb、ALB、eGFR呈负相关(均P<0.05)。外周血LncRNA ANRIL是影响DKD患者LVH的独立危险因素(OR=1.535,95%CI:1.058~2.225,P=0.024),而ALB是DKD患者LVH的保护因素(OR=0.853,95%CI:0.737~0.987,P=0.033)。外周血lncRNA ANRIL预测DKD患者LVH的曲线下面积是0.795,灵敏度为81.4%,特异度为73.9%。结论外周血lncRNA ANRIL可作为DKD肾脏损害的生物标志物,且可作为评估DKD患者LVH的预测指标。 Objective To examine the expressions of long noncoding RNA ANRIL(lncRNA ANRIL)in peripheral blood with diabetic kidney disease(DKD)patients,and to explore the correlation between ANRIL and left ventricular hypertrophy(LVH).Methods From January 2020 to December 2021,66 DKD patients(DKD group)and 20 normal healthy people(control group)were collected.Expressions of lncRNA ANRIL in peripheral blood of all participants were measured by RT-qPCR.DKD patients were divided into non-LVH group(23 cases)and LVH group(43 group)according to left ventricular mass index(LVMI).The differences of ANRIL expressions were examined in the two groups.The logistic regression was explored to analyze the risk factor of LVH in DKD patients.Receiver operating characteristic(ROC)curve was used to evaluate the value of lncRNA ANRIL in predicting LVH in DKD patients.Results The systolic blood pressure(SBP),diastolic blood pressure(DBP),serum creatinine(Scr),blood urea nitrogen(BUN)and cystatin C(Cys C)in DKD patients were higher than those in control group,while hemoglobin(Hb),albumin(ALB)and estimated glomerular filtration rate(eGFR)were lower than those of control group(all P<0.05).The urinary albumin/creatinine ratio(ACR),Scr,BUN,Cys-C,urinaryβ2-microglobulin(β2-MG)and LVMI in LVH group were higher than those in non-LVH group,and Hb,ALB,eGFR were lower than those in non-LVH group,the difference was statistically significant(all P<0.05).The circulating expressions of lncRNA ANRIL in DKD patients were significantly higher than that in control group(P<0.05).lncRNA ANRIL was positively correlated with Scr,BUN and negatively correlated with eGFR(all P<0.05).lncRNA ANRIL expressions in LVH patients were dramatically higher than non-LVH group(P<0.05).ANRIL was positively correlated with LVMI(P<0.05),and ANRIL was an independent risk factor for LVH in DKD patients(OR=1.535,95%CI:1.058-2.225,P=0.024).ALB was a protective factor for LVH in DKD patients(OR=0.85,95%CI:0.737-0.987,P=0.033).The area under the curve of lncRNA ANRIL in predicting LVH in DKD patients was 0.795,the sensitivity was 81.4%and the specificity was 73.9%.Conclusions lncRNA ANRIL in peripheral blood can be used as a biomarker of kidney damage in DKD and as a predictor of LVH assessment in DKD patients.
作者 朱燕亭 代丽霞 陈新田 鲍苗 王琼 Zhu Yanting;Dai Lixia;Chen Xintian;Bao Miao;Wang Qiong(Department of Nephropathy and Hemodialysis,Shaanxi Provincial People′s Hospital,Xi′an 710068,China;Xi′an Medical University,Xi′an 710021,China)
出处 《国际泌尿系统杂志》 2024年第1期138-143,共6页 International Journal of Urology and Nephrology
基金 陕西省自然科学基础研究计划一般项目(2021JQ-905) 陕西省人民医院科技人才支持计划(2021JY-31)。
关键词 糖尿病肾病 LncRNA ANRIL 左心室肥厚 Diabetic Nephropathies LncRNA ANRIL Left Ventricular Hypertrophy
  • 引文网络
  • 相关文献

参考文献2

二级参考文献19

  • 1侯凡凡,马志刚,梅长林,戎殳,黄颂敏,刘先蓉,袁伟杰,郭云珊,王莉,何强,王秀玲,桑晓红,栗霄立.中国五省市自治区慢性肾脏病患者心血管疾病的患病率调查[J].中华医学杂志,2005,85(7):458-463. 被引量:183
  • 2胡锦睿,徐永远,应丽红,曹豪杰.慢性肾衰竭患者早期心脏结构及功能的初步观察[J].现代中西医结合杂志,2007,16(27):3937-3939. 被引量:3
  • 3Collins AJ,Foley RN, Chavers B,et al. United States RenalData System 2011 Annual Data Report: Atlas of chronic kid-ney disease&^end-stage renal disease in the United States[J].Am J Kidney Dis, 2012,59(1 Suppl 1): A7, el-420.
  • 4Foley RN,Gilbertson DT,Murray T,et al. Long interdialyticinterval and mortality among patients receiving hemodialysis[J]. N Engl J Med, 2011, 365(12): 1099-1107.
  • 5Dialysis and Transplantation Registration Group. The reportabout the registration of dialysis and transplantation in China1999[J]. Chin J Nephrol, 2001, 17(2): 77-78.
  • 6Cai QZ, Lu XZ, Lu Y,et al. Longitudinal Changes of CardiacStructure and Function in CKD (CASCADE Study) [J].JASN, 2014,25(7): 1599-1608.
  • 7London GM, Pannier B,Guerin AP, et al. Alterations of leftventricular hypertrophy in and survival of patients receivinghemodialysis: follow-up of an interventional study[J]. J AmSoc Nephrol, 2001,12(12): 2759-2767.
  • 8Kessler M, Zannad F,Lehert P, et al. Predictors of cardio-vascular events in patients with end-stage renal disease : an a-nalysis from the fosinopril in dialysis study [J]. Nephrol IXalTransplant, 2007,22(12): 3573-3579.
  • 9Kidney Disease Improving Global Outcomes, KDIGO 2012Clinical Practice Guideline for the Evaluation and Managementof Chronic Kidney Disease [J]. Kidney International Supple-ments 3,2013,3(1): 19-62.
  • 10Levey AS, Stevens LA, Schmid CH, et al. A new equation toestimate glomerularfiltration rate[J]. Ann Intern Med, 2009,150(9): 604-612.

共引文献6

;
使用帮助 返回顶部